MoleculeX Secures Hundreds of Millions in Series A Funding Amid 2024 Bio & Art Carnival
MoleculeMind
AI Protein Design Platform Developer
Insights into International Trends, Understanding Frontline Dynamics
Walking into Zhongguan Village Life Science Park Monthly
Let's take a look at what's new this month.
Relevant Review
Specialized and Innovative "Little Giant" Enterprises, Life Park +4!
In September, there was a constant stream of good news from the park's enterprises.
In terms of winning awards and recognition,Beijing Institute of BiotechnologySenior Researcher / Tsinghua Institute for Biomedical Cross-disciplinary ResearchProfessor Wen-Hui Li Honored with "Distinguished Achievement Award in Hepatitis B Research"；Toplead BiotechDr. Gao Meng Selected for the 2024 Beijing Science and Technology New Star Program.
In terms of product development,KingMedThe independently developed "2019-nCoV Nucleic Acid Detection Kit (Reversible Terminator Sequencing Method)" and "2019-nCoV Sequencing Data Analysis Software" have been approved for marketing by the National Medical Products Administration;GenePlusAnnouncing the Launch of InCell™ Single-Cell Transcriptomics Product;InnoCare PharmaInitiate Phase III Clinical Study of Orelabrutinib for Primary Progressive Multiple Sclerosis, While BCL2 Inhibitor ICP-248 for Acute Myeloid Leukemia Also Approved for Clinical Trials;Shenji ChanghuaSNUG01 Achieves Positive Clinical Outcomes in the IIT Study at Peking University Third Hospital: No DLT Events Observed During the 28-Day Dose-Limiting Toxicity (DLT) Monitoring, and No Drug-Related Adverse Reactions Greater Than Grade 2 Were Found, Preliminarily Confirming the Safety and Tolerability of SNUG01.
In terms of the capital market,MoleculeMindCompleted Series A Financing, this round of financing amounts to several hundred million RMB. MoleculeMind stated that this financing will further accelerate the construction of AI biological infrastructure; Novo Nordisk and NanoVation Therapeutics have reached a $600 million collaboration. This collaboration aims to advance the development of innovative gene therapies for cardiometabolic diseases and rare diseases.
Corporate News | Topllo Biotech's Innovative Research Published in Top International Journal
In September, the park launched a series of activities.
In terms of industry activities, events such as the training session on the interpretation of high-tech enterprise certification, the ADC drug development seminar, and the China-Brazil pharmaceutical market demand exchange meeting have contributed to the all-round development of enterprises. In terms of ecological activities, the Carnival of Bio & Art 2024 Zhongguancun Life Science Park Carnival concluded successfully amidst the rising autumn breeze and brilliant sunset glow, filled with music, delicious food, joy, and a tinge of reluctance; the Jing Si Lake Lantern Festival was also successfully held at the café on the first floor of Building 6, Yard 20 of the Life Science Park, offering a one-click access to Chinese romance!
Relevant Review
Note: The data is sourced from publicly available information. If there are any omissions, we appreciate your understanding.
